OECD Detailed Review Paper (DRP) number 31 on "Cell Transformation Assays for Detection of Chemical Carcinogens": main results and conclusions
- PMID: 22120692
- DOI: 10.1016/j.mrgentox.2011.11.007
OECD Detailed Review Paper (DRP) number 31 on "Cell Transformation Assays for Detection of Chemical Carcinogens": main results and conclusions
Abstract
The Detailed Review Paper (DRP) number 31 of the Organisation for Economic Co-operation and Development (OECD) analyses the performance of the three models used in Cell Transformation Assays (CTAs) to screen the carcinogenic potential of chemicals: the Syrian hamster embryo (SHE) cells, and the mouse cell lines BALB/c 3T3 and C3H10T1/2. The CTA results have been compared to results from recent genotoxicity tests using mammalian and non-mammalian cell systems. The performance of the CTAs in predicting carcinogenic potential has been established on several hundreds of chemicals, comprising organic and inorganic substances. The results have been analysed and the chemicals classified as rodent and/or human carcinogens. Based on this comparison and on their performance - concordance, sensitivity, specificity, positive and negative predictive capacity, and evidence for intra- and inter-laboratory reproducibility - OECD recommended that the CTAs using the SHE cells (carried out at physiological or acidic pH) and the BALB/c 3T3 cell line should be developed into OECD test guidelines. The CTA using the C3H10T1/2 cell line was considered to be useful to elucidate molecular mechanisms of cell transformation at the genomic and transcriptomic level. However, due to the limited data available on reproducibility, a test guideline was not recommended at that time.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
ECVAM prevalidation study on in vitro cell transformation assays: general outline and conclusions of the study.Mutat Res. 2012 Apr 11;744(1):12-9. doi: 10.1016/j.mrgentox.2011.11.009. Epub 2011 Nov 26. Mutat Res. 2012. PMID: 22138617
-
Prevalidation study of the BALB/c 3T3 cell transformation assay for assessment of carcinogenic potential of chemicals.Mutat Res. 2012 Apr 11;744(1):20-9. doi: 10.1016/j.mrgentox.2011.12.008. Epub 2011 Dec 17. Mutat Res. 2012. PMID: 22198331
-
Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 6.7 for assessment of carcinogenic potential of chemicals.Mutat Res. 2012 Apr 11;744(1):54-63. doi: 10.1016/j.mrgentox.2011.12.005. Epub 2011 Dec 13. Mutat Res. 2012. PMID: 22178964
-
Use of Syrian hamster embryo and BALB/c 3T3 cell transformation for assessing the carcinogenic potential of chemicals.IARC Sci Publ. 1999;(146):409-25. IARC Sci Publ. 1999. PMID: 10353397 Review. No abstract available.
-
Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals.Mutat Res. 1996 Sep 21;356(1):11-63. doi: 10.1016/0027-5107(95)00197-2. Mutat Res. 1996. PMID: 8841474 Review.
Cited by
-
Insulin-IGF signaling affects cell transformation in the BALB/c 3T3 cell model.Sci Rep. 2016 Nov 16;6:37120. doi: 10.1038/srep37120. Sci Rep. 2016. PMID: 27849005 Free PMC article.
-
Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs.Mutagenesis. 2012 Jan;27(1):93-101. doi: 10.1093/mutage/ger053. Epub 2011 Aug 17. Mutagenesis. 2012. PMID: 21852270 Free PMC article.
-
A mechanistic evaluation of the Syrian hamster embryo cell transformation assay (pH 6.7) and molecular events leading to senescence bypass in SHE cells.Mutat Res Genet Toxicol Environ Mutagen. 2016 May;802:50-8. doi: 10.1016/j.mrgentox.2016.04.002. Epub 2016 Apr 9. Mutat Res Genet Toxicol Environ Mutagen. 2016. PMID: 27169376 Free PMC article.
-
In vitro and bioinformatics mechanistic-based approach for cadmium carcinogenicity understanding.Toxicol In Vitro. 2020 Jun;65:104757. doi: 10.1016/j.tiv.2020.104757. Epub 2020 Jan 3. Toxicol In Vitro. 2020. PMID: 31904401 Free PMC article.
-
Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells.Mol Ther Methods Clin Dev. 2021 Sep 10;23:241-253. doi: 10.1016/j.omtm.2021.09.004. eCollection 2021 Dec 10. Mol Ther Methods Clin Dev. 2021. PMID: 34703845 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources